This panel will explore the escalating costs of specialty medications and their impact on health insurance providers, employers, and patients. Experts will discuss innovative financial strategies to ensure sustainable access, including value-based contracting, formulary management, and the integration of biosimilars. Attendees will gain insights into balancing cost containment with quality care to meet both business and member needs. The session will also examine collaborative approaches between payers, providers, and pharmaceutical companies to drive affordability and improve patient outcomes.